Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-protein Oral Supplement Improves Normalized Protein Catabolic Rate and Inflammation Markers

NCT05227755 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT05227755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05227755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-protein Oral Supplement Improves Normalized Protein Catabolic Rate and Inflammation Markers
Lead sponsor
University of Florida
Phase
Not applicable
Overall status
Completed
Start date
August 5, 2022
Completion date
November 21, 2023
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease requiring chronic dialysis, renal failure